Research Links

Our staff has deemed the following public research links as significant and/or new findings by the global research community in the search for a cure for paralysis.  You can search the database by category, keyword, name, and/or date.  Keep abreast of cure research breakthroughs by signing up for our monthly research newsletter. 

Sign up to receive monthly research updates.

 

Please note that the research posted here is not affiliated with the MCPF unless that is specifically stated.

Current Articles | Categories | Search

Acorda Reports Spinal Cord Injury Miss, Positive Trends Seen In MS

I was a mixed day for Acorda Therapeutics Inc., which said Fampridine-SR missed its endpoints in two pivotal Phase III trials in spinal cord injury (SCI), but also said the drug showed positive trends in a Phase II multiple sclerosis (MS) trial.

Acorda plans to pursue the MS indication, conducting either another Phase II trial or a Phase III trial depending on what comes out of upcoming meetings with the FDA.

Those meetings also will determine whether the company will continue development in the SCI indication.

 

http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=32529

posted @ Thursday, April 15, 2004 12:00 AM by host

Previous Page | Next Page

Latest Research Articles
 
Light Therapy Will Cure Nerve Damage
Tiny emitters near the spinal cord will release fl...
Key Mechanism That Regulates Development Of Stem Cells Into Neurons Identified
Researchers at the University of Southern Californ...
Coaxing Injured Nerves to Regrow
The adult central nervous system has limited abili...
Repairing the Damaged Spinal Cord
Editor's Note: This story, originally printed in t...


 

Morton Cure Paralysis Fund
P.O. Box 580396
Minneapolis, Minnesota 55458-0396
(612) 904-1420
info@mcpf.org

 
 

Terms Of Use | Privacy Statement
Copyright (c) 2009 Morton Cure Paralysis Fund